Landscapes / Targets
KAT6
6 drugs act on KAT6, in 8 active trials · Any stage · updated 18 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs6
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 12 May 2028Phase 1/2 trial completes | |||
| Next date | 12 May 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Advanced Breast Cancer, Hematological Malignancy | ||||
| Open drug page | |||||
— |
Phase 1 | 30 May 2027Phase 1 trial completes | |||
| Next date | 30 May 2027 · Phase 1 trial completes | ||||
| Also tested for | Advanced or Metastatic ER+ HER2- Breast Cancer (mBC), Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) and 4 more | ||||
| Open drug page | |||||
— |
Henlius · Public 2696.HK |
Phase 1 | Mar 2028Phase 1 trial completes | ||
| Next date | Mar 2028 · Phase 1 trial completes | ||||
| Also tested for | Advanced/Metastatic Solid Tumors | ||||
| Open drug page | |||||
— |
Phase 1 | 30 Sep 2028Phase 1 trial completes | |||
| Next date | 30 Sep 2028 · Phase 1 trial completes | ||||
| Also tested for | Breast Cancer, Advanced Solid Tumor and 1 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Oct 2028Phase 1 trial completes | |||
| Next date | 31 Oct 2028 · Phase 1 trial completes | ||||
| Also tested for | Breast Cancer, Hormone-receptor-positive Breast Cancer and 5 more | ||||
| Open drug page | |||||
— |
Phase 1 | 31 Dec 2029Phase 1 trial completes | |||
| Next date | 31 Dec 2029 · Phase 1 trial completes | ||||
| Also tested for | Cancer | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 6 of 6 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 · openFDA updated 17 Nov 2026